Because semaglutide influences digestion and appetite, your gastrointestinal system can be sensitive early in treatment
This means immense potential for market growth as they transform the landscape of obesity treatment
Schedule your FREE, no-pressure consultation with Majestic Aesthetics today
Asia-Pacific is the fastest-growing region, fueled by rising diabetes and obesity rates in China, India, and Southeast Asia, increasing healthcare access and diagnosis, growing acceptance of GLP-1 agonists for glycemic control and weight management, expanding retail and online pharmacy channels, and aggressive market entry by global players
Fluid-based IV drips hydrate the body more effectively than mere water consumption
They also recommend limiting intake of saturated fat, sweets, sugar-sweetened beverages, and red meat